Hot Features
Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Following the announcement on 22 September 2011, American Medical Alert Corp (Nasdaq: AMAC), a leading provider of remote health monitoring and 24/7 communication services that...
American Medical Alert Corp. (Nasdaq: AMAC), today announced that AMAC and other named defendants have entered into a memorandum of understanding (MOU) with plaintiffs’ counsel...
Levi & Korsinsky is investigating the Board of Directors of American Medical Alert Corp. (“AMAC” or the “Company”) (NASDAQ: AMAC) for possible breaches of fiduciary duty and...
Glancy Binkow & Goldberg LLP is continuing its investigation of potential claims against the Board of Directors of American Medical Alert Corp. (“American Medical” or the...
Former United States Securities and Exchange Commission attorney Willie Briscoe and the securities litigation firm of Powers Taylor, LLP are investigating the acquisition of...
The Law Firm of Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of American Medical Alert Corp. in Connection with the Sale of the Company to...
Ryan & Maniskas, LLP (www.rmclasslaw.com/cases/amac) is investigating potential claims against the board of directors of American Medical Alert Corp. ("American Medical" or the...
Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of American Medical Alert Corp. (“American Medical Alert”...
Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of American Medical Alert Corp. (“American...
Law Offices of Howard G. Smith announces that it is investigating potential claims against the Board of Directors of American Medical Alert Corp. (“American Medical” or the...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| Keine Diskussionen Gefunden. |
| Neuen Thread Erstellen |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
